Mayer B, Klatt P, Werner E R, Schmidt K
Institut für Pharmakologie und Toxikologie, Karl-Franzens-Universität Graz, Austria.
FEBS Lett. 1994 Aug 22;350(2-3):199-202. doi: 10.1016/0014-5793(94)00766-7.
Imidazole acts as a heme-site inhibitor of nitric oxide synthase (NOS). We used this compound to investigate whether the substrate L-arginine binds directly to the heme or to a separate domain of brain NOS. Enzyme kinetic experiments showed that imidazole enhanced the apparent Km for L-arginine without affecting maximal enzyme activity, and binding studies revealed that the inhibitor displaced the radioligand NG-nitro-L-[3H]arginine in a concentration-dependent fashion. These results demonstrate that imidazole exerts its effects on NOS in an L-arginine-competitive manner and that the substrate site of the enzyme may be identical with the prosthetic heme group.
咪唑作为一氧化氮合酶(NOS)的血红素位点抑制剂。我们使用该化合物来研究底物L-精氨酸是直接与血红素结合还是与脑NOS的一个独立结构域结合。酶动力学实验表明,咪唑增加了L-精氨酸的表观Km值,而不影响最大酶活性,结合研究表明,该抑制剂以浓度依赖的方式取代放射性配体NG-硝基-L-[3H]精氨酸。这些结果表明,咪唑以L-精氨酸竞争性方式对NOS发挥作用,并且该酶的底物位点可能与辅基血红素基团相同。